Recent Quotes (30 days)

You have no recent quotes
chg | %

Hamilton Thorne Ltd  

(Public, CVE:HTL)   Watch this stock  
Find more results for HTL
0.410
Apr 24 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.05 - 0.51
Open     -
Vol / Avg. 0.00/37,132.00
Mkt cap 24.51M
P/E 26.73
Div/yield     -
EPS 0.02
Shares 59.60M
Beta 3.02
Inst. own     -
Apr 23, 2015
Q4 2014 Hamilton Thorne Ltd Earnings Release
  

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 7.17% 1.67%
Operating margin 10.04% 5.44%
EBITD margin - 5.70%
Return on average assets 25.75% 6.04%
Return on average equity - -
CDP Score - -

Address

100 Cummings Ctr Ste 465e
BEVERLY, MA 01915-6143
United States - Map
+1-978-9212050 (Phone)
+1-978-9210250 (Fax)

Website links

Description

Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company�s customers include Harvard, MIT, Yale, McGill, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, and Oxford and Cambridge. The Company�s Computer Assisted Sperm Analysis (CASA) image analysis systems are designed for the study of reproductive cells in the human fertility, animal sciences and reproductive toxicology fields. The Company sells its products through its direct sales force and through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments around the world.

Officers and directors

Meg D. Spencer Chairman of the Board
David Wolf President, Chief Executive Officer, Director
Michael W. Bruns CPA Chief Financial Officer, Vice President - Finance
Age: 55
Diarmaid H. Douglas-Hamilton Corporate Secretary, Chief Technology Officer and Senior Vice-President - Research & Development of the Corporation, Director
Thomas Kenny Vice President - Engineering
Dean Gendron Independent Director
Bruno C. Maruzzo Independent Director
Age: 60
Robert J. Potter Independent Director
David B. Sable M.D. Independent Director
Daniel K. Thorne Independent Director
Age: 52